In this first prospective study of circulating (blood and CSF) concentrations of selenoprotein P and dementia risk, greater concentrations were generally predictive of higher risk, particularly when exposure assessment was based on the full-length protein assay AA3. The gene discussed is SELENOP; the disease is dementia.